Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis

Annals of Internal Medicine

Volumn 155, Issue 1, 2011, Pages 65-

  Yun, Jeong H ^a  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNITY; AUTOLOGOUS STEM CELL TRANSPLANTATION; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; LEG REVASCULARIZATION; LETTER; LIMB ISCHEMIA; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

EID: 79960047839     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-155-1-201107050-00013     Document Type: Letter

References (4)

1. Guiducci S, Porta F, Saccardi R, Guidi S, Ibba-Manneschi L, Manetti M, et al. Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report. Ann Intern Med. 2010;153:650-4.
2. Kode JA, Mukherjee S, Joglekar MV, Hardikar AA. Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy. 2009;11:377-91.
3. Bocelli-Tyndall C, Bracci L, Spagnoli G, Braccini A, Bouchenaki M, Ceredig R, et al. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneicstimulated lymphocytes in vitro. Rheumatology (Oxford). 2007;46:403-8.
4. Del Papa N, Quirici N, Soligo D, Scavullo C, Cortiana M, Borsotti C, et al. Bone marrow endothelial progenitors are defective in systemic sclerosis. Arthritis Rheum. 2006;54:2605-15.